| pubmed-article:9453531 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C0018802 | lld:lifeskim |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C0042402 | lld:lifeskim |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C0128513 | lld:lifeskim |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C0205267 | lld:lifeskim |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C0205088 | lld:lifeskim |
| pubmed-article:9453531 | lifeskim:mentions | umls-concept:C0439611 | lld:lifeskim |
| pubmed-article:9453531 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9453531 | pubmed:dateCreated | 1998-2-10 | lld:pubmed |
| pubmed-article:9453531 | pubmed:abstractText | End-stage congestive heart failure (CHF) is associated with a high mortality rate and is often refractory to standard medical treatment. Although parenteral inotropes have been beneficial in hospitalized patients, their use in outpatients has been limited by toxicity and tachyphylaxis. | lld:pubmed |
| pubmed-article:9453531 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9453531 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9453531 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9453531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9453531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9453531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9453531 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9453531 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9453531 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:9453531 | pubmed:issn | 0002-8703 | lld:pubmed |
| pubmed-article:9453531 | pubmed:author | pubmed-author:ClarkJJ | lld:pubmed |
| pubmed-article:9453531 | pubmed:author | pubmed-author:MaiselAA | lld:pubmed |
| pubmed-article:9453531 | pubmed:author | pubmed-author:CesarioDD | lld:pubmed |
| pubmed-article:9453531 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9453531 | pubmed:volume | 135 | lld:pubmed |
| pubmed-article:9453531 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9453531 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9453531 | pubmed:pagination | 121-9 | lld:pubmed |
| pubmed-article:9453531 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:meshHeading | pubmed-meshheading:9453531-... | lld:pubmed |
| pubmed-article:9453531 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9453531 | pubmed:articleTitle | Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. | lld:pubmed |
| pubmed-article:9453531 | pubmed:affiliation | Division of Cardiology, Veterans Affairs Medical Center, and University of California, San Diego, USA. | lld:pubmed |
| pubmed-article:9453531 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9453531 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9453531 | lld:pubmed |
